References
- P. Pacher, A. Nivorozhkin, and C. Szabo, "Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol", Pharmacol. Rev., Vol. 58, pp. 87-114, 2006. https://doi.org/10.1124/pr.58.1.6
- D. A. Parks and D. N. Granger, "Xanthine oxidase: biochemistry, distribution and physiology", Acta Physiologica Scandinavica. Supplementum, Vol. 548, pp. 87-99, 1986.
- M. Cicoira, L. Zanolla, A. Rossi, G. Golia, L. Franceschini, G. Brighetti, P. Zeni, and P. Zardini, "Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy", Am. Heart J., Vol. 143, pp. 1107-1111, 2002. https://doi.org/10.1067/mhj.2002.122122
- K. D. Pfeffer, T. P. Huecksteadt, and J. R. Hoidal, "Xanthine dehydrogenase and xanthine oxidase activity and gene expression in renal epithelial cells. Cytokine and steroid regulation", J. Immunol., Vol. 153, pp. 1789-1797, 1994.
- R. Guerciolini, C. Szumlanski, and R. M. Weinshilboum, "Human liver xanthine oxidase: nature and extent of individual variation", Clin. Pharmacol. Ther., Vol. 50, pp. 663-672, 1991. https://doi.org/10.1038/clpt.1991.205
- R Harrison, "Structure and function of xanthine oxidoreductase: where are we now?", Free Radical Biol. Med., Vol. 33, pp. 774-797, 2002. https://doi.org/10.1016/S0891-5849(02)00956-5
- R Harrison, "Physiological roles of xanthine oxidoreductase", Drug Metab. Rev., Vol. 36, pp. 363-375, 2004. https://doi.org/10.1081/DMR-120037569
- H. M. Kramer and G. Curhan, "The association between gout and nephrolithiasis: the national health and nutrition examination survey III, 1988-1994", Am. J. Kidney Dis., Vol. 40, pp. 37-42, 2002. https://doi.org/10.1053/ajkd.2002.33911
- H. K. Choi and G. Curhan, "Gout: epidemiology and lifestyle choices", Curr. Opin. Rheumatol., Vol. 17, pp. 341-345, 2005.
- R. L. Wortmann, "Recent advances in the management of gout and hyperuricemia", Curr. Opin. Rheumatol., Vol. 17, pp. 319-324, 2005. https://doi.org/10.1097/01.bor.0000162060.25895.a5
- J. George and A. D. Struthers, "The role of urate and xanthine oxidase inhibitors in cardiovascular disease", Cardiovasc. Ther., Vol. 26, pp. 59-64, 2008.
- N. Dalbeth and L. Stamp, "Allopurinol Dosing in Renal Impairment: Walking the Tightrope Between Adequate Urate Lowering and Adverse Events", Semin. Dialysis, Vol. 20, pp. 391-395, 2007. https://doi.org/10.1111/j.1525-139X.2007.00270.x
- T.-F. Tsai and T.-Y. Yeh, "Allopurinol in dermatology", Am. J. Clin. Dermatol., Vol. 11, pp. 225-232, 2010. https://doi.org/10.2165/11533190-000000000-00000
- B. L. Love, R. Barrons, A. Veverka, and K. M. Snider, "Urate-lowering therapy for gout: focus on febuxostat", Pharmacotherapy, Vol. 30, pp. 594-608, 2010. https://doi.org/10.1592/phco.30.6.594
- J. U. Song, S. P. Choi, T. H. Kim, C.-K. Jung, J.-Y. Lee, S.-H. Jung, and G. T. Kim, "Design and synthesis of novel 2-(indol-5-yl)thiazole derivatives as xanthine oxidase inhibitors", Bioorg. Med. Chem. Lett., Vol. 25, pp. 1254-1258, 2015. https://doi.org/10.1016/j.bmcl.2015.01.055
- K. Abe, H. Shimokawa, K. Morikawa, T. Uwatoku, K. Oi, Y. Matsumoto, T. Hattori, Y. Nakashima, K. Kaibuchi, K. Sueishi, and A. Takeshit, "Long-term treatment with a Rho-kinase inhibitor improves monocrotaline-induced fatal pulmonary hypertension in rats", Circ. Res., 94: 385-393, 2004. https://doi.org/10.1161/01.RES.0000111804.34509.94
- T. Ishizaki, M. Uehata, I. Tamechika, J. Keel, K. Nonomura, M. Maekawa, and S. Narumiya, "Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases", Mol. Pharmacol., Vol. 57, pp. 976-983, 2000.
- P. Geladi and B. Kowalski, "Partial least-squares regression: a tutorial", Anal. Chim. Acta, Vol. 185, pp. 1-17, 1986. https://doi.org/10.1016/0003-2670(86)80028-9
- S. Wold, "Cross-validatory estimation of the number of components in factor and principal components models", Technometrics, Vol. 20, pp. 397-405, 1978. https://doi.org/10.1080/00401706.1978.10489693
- N. Santhosh Kumar and M. Thirumurthy, "3D-QSAR Studies on 2-(indol-5-yl)thiazole Derivatives as Xanthine Oxidase (XO) Inhibitors", J. Chosun Natural Sci., Vol. 8, pp. 258-266, 2015. https://doi.org/10.13160/ricns.2015.8.4.258